The 53rd annual meeting of the American Society of Clinical Oncology (ASCO) will be held in Chicago from June 2-6, 2017. This audio-only podcast features Informa Pharma Intelligence analysts Dr. Robert Jeng (Biomedtracker), Dr. David Dahan (Biomedtracker), Dr. Dominique Fontanilla (Datamonitor Healthcare), and Dr. Maria Berezina (Citeline) as they discuss notable abstracts which were released on Wednesday, May 17, 2017. Podcast topics include:

• IDO inhibitors epacadostat and RG6078
• PD-1 inhibitor Keytruda in gastric cancer
• CAR-T therapies bb2121 and CTL119
• Breast cancer including Perjeta and PARP inhibitors

For more highlights, see our Pre-ASCO Report.